Results 231 to 240 of about 1,617,748 (250)
Some of the next articles are maybe not open access.

A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

Frontiers in Oncology, 2021
Zheling Chen
exaly  

Modelling the time variable spectral energy distribution of the blazar CTA 102 from 2008 to 2022

Monthly Notices of the Royal Astronomical Society, 2022
N Sahakyan   +2 more
exaly  

Valorization of chicken feather waste into bioactive keratin hydrolysate by a newly purified keratinase from Bacillus sp. RCM-SSR-102

Journal of Environmental Management, 2020
Pintubala Kshetri   +2 more
exaly  

Effects and risk factors of TAS-102 in real-world patients with metastatic colorectal cancer, EROTAS-R study

International Journal of Clinical Oncology, 2023
Naohisa Yoshida   +2 more
exaly  

A Comparison of Regorafenib and TAS-102 for Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis

Clinical Colorectal Cancer, 2018
Yoo-Joung Ko   +2 more
exaly  

TAS-102, a novel antitumor agent: A review of the mechanism of action

Cancer Treatment Reviews, 2015
Sebastian Stintzing, Fotios Loupakis
exaly  

Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102

Clinical Colorectal Cancer, 2017
Kentaro Yamazaki   +2 more
exaly  

Exceptional outburst of the blazar CTA 102 in 2012: the GASP–WEBT campaign and its extension

Monthly Notices of the Royal Astronomical Society, 2016
V M Larionov, M Villata, C M Raiteri
exaly  

Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer

Annals of Oncology, 2017
Marta Schirripa   +2 more
exaly  

Modification of kelp and sludge biochar by TMT-102 and NaOH for cadmium adsorption

Journal of the Taiwan Institute of Chemical Engineers, 2020
Bing Li, Xiaomei Lv
exaly  
previous   22  23  24  25  

Home - About - Disclaimer - Privacy